IRIS
SOLIMANDO, ANTONIO GIOVANNI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.427
AS - Asia 3.353
EU - Europa 2.574
SA - Sud America 885
AF - Africa 173
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 3
Totale 13.421
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.273
SG - Singapore 1.518
BR - Brasile 774
CN - Cina 676
IT - Italia 630
HK - Hong Kong 480
RU - Federazione Russa 438
SE - Svezia 414
DE - Germania 331
VN - Vietnam 277
FR - Francia 184
GB - Regno Unito 180
FI - Finlandia 91
CA - Canada 86
IN - India 80
ID - Indonesia 76
CI - Costa d'Avorio 67
PL - Polonia 52
MX - Messico 45
BD - Bangladesh 41
NL - Olanda 40
BE - Belgio 37
JP - Giappone 37
AR - Argentina 36
CZ - Repubblica Ceca 35
ZA - Sudafrica 35
ES - Italia 33
AT - Austria 27
TR - Turchia 27
KR - Corea 23
LT - Lituania 20
UA - Ucraina 20
EG - Egitto 19
EC - Ecuador 17
IQ - Iraq 16
AE - Emirati Arabi Uniti 14
VE - Venezuela 14
JO - Giordania 13
CL - Cile 12
UZ - Uzbekistan 12
MA - Marocco 11
PK - Pakistan 11
CO - Colombia 10
PY - Paraguay 10
TN - Tunisia 10
IE - Irlanda 9
IR - Iran 8
KE - Kenya 7
SA - Arabia Saudita 7
AU - Australia 6
CH - Svizzera 6
DZ - Algeria 5
MY - Malesia 5
PE - Perù 5
UY - Uruguay 5
DK - Danimarca 4
KW - Kuwait 4
NP - Nepal 4
PA - Panama 4
ET - Etiopia 3
HU - Ungheria 3
LB - Libano 3
NO - Norvegia 3
PS - Palestinian Territory 3
QA - Qatar 3
SN - Senegal 3
TT - Trinidad e Tobago 3
AO - Angola 2
AZ - Azerbaigian 2
BB - Barbados 2
BG - Bulgaria 2
BO - Bolivia 2
DO - Repubblica Dominicana 2
EE - Estonia 2
GM - Gambi 2
HR - Croazia 2
HT - Haiti 2
JM - Giamaica 2
LA - Repubblica Popolare Democratica del Laos 2
NI - Nicaragua 2
RO - Romania 2
SK - Slovacchia (Repubblica Slovacca) 2
XK - ???statistics.table.value.countryCode.XK??? 2
ZM - Zambia 2
AF - Afghanistan, Repubblica islamica di 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BJ - Benin 1
BW - Botswana 1
CG - Congo 1
CU - Cuba 1
CW - ???statistics.table.value.countryCode.CW??? 1
GD - Grenada 1
GE - Georgia 1
GH - Ghana 1
GR - Grecia 1
GT - Guatemala 1
IL - Israele 1
KH - Cambogia 1
KZ - Kazakistan 1
Totale 13.405
Salva come PNG Salva come JPEG
Città #
Ashburn 949
Singapore 819
Chandler 605
Fairfield 570
Hong Kong 475
Nyköping 341
Woodbridge 304
Houston 253
Seattle 251
Beijing 249
Cambridge 233
New York 209
Ann Arbor 201
Bari 187
Wilmington 176
Los Angeles 175
Dallas 134
Munich 114
Dearborn 100
Roxbury 93
Lawrence 92
Ho Chi Minh City 86
Marseille 81
São Paulo 70
Des Moines 69
Abidjan 67
Jakarta 66
Brooklyn 63
Moscow 60
Rome 60
Hanoi 52
Chicago 51
Buffalo 50
Helsinki 47
San Diego 45
London 44
Nanjing 44
Santa Clara 44
Boardman 41
Frankfurt am Main 41
Inglewood 40
Dong Ket 39
Brussels 37
Turku 36
Tokyo 35
Denver 32
Falkenstein 32
Warsaw 32
Orem 31
Toronto 31
Council Bluffs 29
Stockholm 29
Brno 26
Johannesburg 25
Milan 25
Montreal 25
Jacksonville 24
Paris 24
Chennai 23
Poplar 23
Redwood City 23
Nuremberg 22
Boston 20
Phoenix 20
Manchester 19
Princeton 19
The Dalles 19
Washington 19
Guangzhou 18
San Jose 18
Columbus 17
Rio de Janeiro 17
Campinas 16
Leawood 16
Salt Lake City 16
Shanghai 15
Atlanta 14
Augusta 14
Curitiba 14
San Francisco 14
Shenyang 14
Tampa 14
Amsterdam 13
Belo Horizonte 13
Brasília 13
Kunming 13
Mexico City 13
Pune 13
Amman 12
Grafing 12
Haiphong 12
Salvador 12
Cairo 11
Dhaka 11
Mumbai 11
Nanchang 11
Tashkent 11
Torrile 11
Ankara 10
Hefei 10
Totale 8.799
Salva come PNG Salva come JPEG
Nome #
Adhesion-Mediated Multiple Myeloma (MM) Disease Progression: Junctional Adhesion Molecule a Enhances Angiogenesis and Multiple Myeloma Dissemination and Predicts Poor Survival 274
Halting the vicious cycle within the multiple myeloma ecosystem: blocking JAM-A on bone marrow endothelial cells restores the angiogenic homeostasis and suppresses tumor progression 218
Central Function for JAM-a in Multiple Myeloma Patients with Extramedullary Disease. 200
Bone marrow fibroblasts overexpress miR-27b and miR-214 in step with multiple myeloma progression, dependent on tumour cell-derived exosomes 197
Bone marrow endothelial cells sustain a tumor-specific CD8+ T cell subset with suppressive function in myeloma patients 188
B-Cell Therapies in Relapsing Remitting and Primary Progressive Multiple Sclerosis: A Short Clinical Review 169
The small subunit of Hemilipin2, a new heterodimeric phospholipase A2 from Hemiscorpius lepturus scorpion venom, mediates the antiangiogenic effect of the whole protein 165
High-Risk Multiple Myeloma: Integrated Clinical and Omics Approach Dissects the Neoplastic Clone and the Tumor Microenvironment 165
JAM-A as a Prognostic Factor and New Therapeutic Target in Multiple Myeloma 164
CAFs and TGF-β Signaling Activation by Mast Cells Contribute to Resistance to Gemcitabine/Nabpaclitaxel in Pancreatic Cancer 161
Early echocardiographic detection of left ventricular diastolic dysfunction in patients with systemic lupus erythematosus asymptomatic for cardiovascular disease 161
Targeting B-cell non Hodgkin lymphoma: New and old tricks 159
Gene Expression Comparison between the Lymph Node-Positive and -Negative Reveals a Peculiar Immune Microenvironment Signature and a Theranostic Role for WNT Targeting in Pancreatic Ductal Adenocarcinoma: A Pilot Study 159
Microenvironment drug resistance in multiple myeloma: Emerging new players 158
Emerging role of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma 158
HB-EGF–EGFR Signaling in Bone Marrow Endothelial Cells Mediates Angiogenesis Associated with Multiple Myeloma 152
Novel targeting of phospho-cMET overcomes drug resistance and induces antitumor activity in multiple myeloma 146
Skeletal Metastases of Unknown Primary: Biological Landscape and Clinical Overview 144
Bone metastasis as primary presentation of pancreatic ductal adenocarcinoma: A case report and literature review 144
Suspected Pericardial Tuberculosis Revealed as an Amyloid Pericardial Mass 141
JAM-A as a prognostic factor and new therapeutic target in multiple myeloma 140
A multiple myeloma that progressed as type i cryoglobulinemia with skin ulcers and foot necrosis: A case report 138
Inhibition of focal adhesion kinase overcomes resistance of mantle cell lymphoma to ibrutinib in the bone marrow microenvironment 137
BL1391: an established cell line from a human malignant peripheral nerve sheath tumor with unique genomic features 130
Bortezomib treatment modulates autophagy in multiple myeloma 128
Dyspnea, Fatigue, and Generalized Weakness in a 67-Year-Old Man: Approach to the Patient Between Guidelines and Clinical Judgment 127
Targeting angiogenesis in multiple myeloma by the VEGF and HGF blocking DARPin® protein MP0250: a preclinical study 126
Anti-angiogenesis and Immunotherapy: Novel Paradigms to Envision Tailored Approaches in Renal Cell-Carcinoma 124
Emerging Concepts in Acute Heart Failure: From the Pathophysiology to the Clinical Case Based Approach 122
Inhibition of mTOR complex 2 restrains tumor angiogenesis in multiple myeloma 120
Long‐term survival of an advanced colorectal cancer patient treated with Regorafenib: Case report and literature review 120
Insights into the Regulation of Tumor Angiogenesis by Micro-RNAs 118
Immune Checkpoint Inhibitor-Related Myositis: From Biology to Bedside 118
A HGF/cMET autocrine loop is operative in multiple myeloma bone marrow endothelial cells and may represent a novel therapeutic target 117
Predictive and Prognostic Factors in HCC Patients Treated with Sorafenib 116
A comprehensive biological and clinical perspective can drive a patient-tailored approach to multiple myeloma: Bridging the gaps between the plasma cell and the neoplastic niche 116
Angiogenesis and Antiangiogenesis in Multiple Myeloma 115
Short-Term Variations in Neutrophil-to-Lymphocyte and Urea-to-Creatinine Ratios Anticipate Intensive Care Unit Admission of COVID-19 Patients in the Emergency Department 115
CIC Mutation as a Molecular Mechanism of Acquired Resistance to Combined BRAF‐MEK Inhibition in Extramedullary Multiple Myeloma with Central Nervous System Involvement 113
Rhu-Epo down-regulates pro-tumorigenic activity of cancer-associated fibroblasts in multiple myeloma 112
Bortezomib Treatment Modulates Autophagy in Multiple Myeloma 110
Actors on the scene: Immune cells in the myeloma niche 110
circPVT1 and PVT1/AKT3 show a role in cell proliferation, apoptosis, and tumor subtype-definition in small cell lung cancer 109
CIC-Mutation As a Potential Molecular Mechanism of Acquired Resistance to Combined BRAF/MEK Inhibition in CNS Multiple Myeloma 108
RAL GTPases mediate multiple myeloma cell survival and are activated independently of oncogenic RAS 107
Amyloid heart involvement lead a fast fatal evolution a healthy woman: a case report 105
Antibiotic treatment in vasculitic leg ulcers: a single center experience 101
Bamlanivimab and Etesevimab administered in an outpatient setting for SARS-CoV-2 infection 101
A Systematic Review on the Therapeutic Potentiality of PD-L1-Inhibiting MicroRNAs for Triple-Negative Breast Cancer: Toward Single-Cell Sequencing-Guided Biomimetic Delivery 100
Imaging evaluation of pulmonary and non-ischaemic cardiovascular manifestations of covid-19 100
Sonography of superficial lymph nodes in malignant lymphomas. Data from our case series. 99
Antibiotics or No Antibiotics, That Is the Question: An Update on Efficient and Effective Use of Antibiotics in Dental Practice 99
Exploration of Artificial Intelligence Use with ARIES in Multiple Myeloma Research 98
Cytotoxic t-lymphocyte antigen-4 in colorectal cancer: Another therapeutic side of capecitabine 98
Fever, cough and breathlessness in a patient with digeorge syndrome 96
Proangiogenic effect of bone marrow fibroblasts in patients with multiple myeloma 96
Effect of thyroidectomy on circulating angiogenic cytokines in papillary thyroid carcinoma and benign goiter: Potential for new biomarkers? 95
Case Report: Lymphocytosis Associated With Fatal Hepatitis in a Thymoma Patient Treated With Anti-PD1: New Insight Into the Immune-Related Storm 94
Right Heart Changes Impact on Clinical Phenotype of Amyloid Cardiac Involvement: A Single Centre Study 91
Efficacy and safety of benralizumab in eosinophilic granulomatosis with polyangiitis: A meta‐analysis of eight studies 90
Two-year follow-up after drug desensitization in mucopolysaccharidosis 87
Real-life experience with omalizumab in chronic spontaneous urticaria. 87
Rituximab induces a reduction of lymphocyte CD3+ activated in patients with autoimmune diseases 86
Mechanisms of Resistance to Anti-CD38 Daratumumab in Multiple Myeloma 86
Folates dysmetabolism promotes atrial cardiomyopathy/fibrillation through a cardiac-bone marrow networking involving endothelial progenitor cell dysfunction and erythropoiesis diversion 84
MicroRNAs as a Potential New Preventive Approach in the Transition from Asymptomatic to Symptomatic Multiple Myeloma Disease 84
Cardiovascular risk in patients with Takayasu arteritis directly correlates with diastolic dysfunction and inflammatory cell infiltration in the vessel wall: a clinical, ex vivo and in vitro analysis. 83
A t(4;13)(q21;q14) translocation in B-cell chronic lymphocytic leukemia causing concomitant homozygous DLEU2/miR15a/miR16-1 and heterozygous ARHGAP24 deletions 83
Induction therapy and stem cell mobilization in patients with newly diagnosed multiple myeloma 82
A Challenging Case of Visceral Leishmaniasis 81
Rituximab use in autoimmune diseases: a single center experience. 81
An atypical presentation of intestinal neuroendocrine tumor. 80
Myeloma cells regulate miRNA transfer from fibroblast-derived exosomes by expression of lncRNAs 80
Telemedicine DSS-AI Multi Level Platform for Monoclonal Gammopathy Assistance 79
Complete Response of Synchronous Liver Metastasis in a Pancreatic Ductal Adenocarcinoma: Could Surgery Represent a Therapeutic Option? 78
null 77
Prognostic role of neoplastic markers in Takotsubo syndrome 77
Immune escape of multiple myeloma cells results from low miR29b and the ensuing epigenetic silencing of proteasome genes 76
Immune system and bone microenvironment: rationale for targeted cancer therapies 76
Difference in growth hormone response to growth hormone-releasing hormone (GHRH) testing following GHRH subacute treatment in normal aging and growth hormone-deficient adults: Possible perspectives for therapeutic use of GHRH or its analogs in elderly subjects? 75
A Novel Automatic Algorithm to Support Lung Ultrasound Non-Expert Physicians in Interstitial Pneumonia Evaluation: A Single-Center Study 73
Breaking through Multiple Myeloma: A Paradigm for a Comprehensive Tumor Ecosystem Targeting 73
The Evolving Role of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma Treatment 72
Epstein–Barr Virus in Salivary Samples from Systemic Lupus Erythematosus Patients with Oral Lesions 72
Angiogenesis as Therapeutic Target in Metastatic Prostate Cancer – Narrowing the Gap Between Bench and Bedside 71
Aplastic Anemia as a Roadmap for Bone Marrow Failure: An Overview and a Clinical Workflow 70
Liquid biopsy and tumor heterogeneity in metastatic solid tumors: the potentiality of blood samples 70
CORRELATION BETWEEN VASCULAR INFLAMMATION MARKERS, DIASTOLIC DYSFUNCTION AND CARDIOVASCULAR RISK IN PATIENTS WITH TAKAYASU ARTERITIS 68
Aggressive systemic mastocytosis with the co-occurrence of PRKG2::PDGFRB, KAT6A::NCOA2, and RXRA::NOTCH1 fusion transcripts and a heterozygous RUNX1 frameshift mutation 68
Lung Ultrasound Is Useful for Evaluating Lung Damage in COVID-19 Patients Treated with Bamlanivimab and Etesevimab: A Single-Center Pilot Study 68
Editorial: Angiogenesis blockade for the treatment of gastrointestinal cancer 68
COVID-19 and the Endocrine System: A Comprehensive Review on the Theme 68
Identification and monitoring of Copy Number Variants (CNV) in monoclonal gammopathy 68
A Markov model for estimating the cost-effectiveness of immunotherapy for newly diagnosed multiple myeloma patients 68
Gene Expression Comparison between Alcohol-Exposed Versus Not Exposed Pancreatic Ductal Adenocarcinoma Patients Reveals a Peculiar TGFβ-Related Phenotype: An Exploratory Analysis 67
Comprehensive analysis of clinical outcomes, infectious complications and microbiological data in newly diagnosed multiple myeloma patients: a retrospective observational study of 92 subjects 67
Genomic profiling at a single center cracks the code in inborn errors of immunity 66
Subcutaneous immunoglobulins in patients with multiple myeloma and secondary hypogammaglobulinemia: a randomized trial 66
Targeting the immune microenvironment in Waldenström Macroglobulinemia via halting the CD40/CD40-ligand axis 65
CARDIOVASCULAR RISK SCORE MAY BE USEFUL IN STRATIFY DEATH RISK IN HOSPITALIZED COVID19 PATIENTS 65
Totale 10.877
Salva come PNG Salva come JPEG
Categoria #
all - tutte 69.086
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 69.086
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021845 0 0 0 0 0 127 159 130 81 129 90 129
2021/2022941 79 36 30 33 40 84 38 50 76 82 135 258
2022/20231.550 155 220 128 123 145 170 43 186 280 26 50 24
2023/2024866 48 121 54 76 75 258 32 21 20 24 16 121
2024/20253.613 150 57 172 130 134 313 538 355 160 220 522 862
2025/20264.239 1.066 374 498 903 1.019 379 0 0 0 0 0 0
Totale 14.338